SCHEMBL2232280

SCHEMBL2232280

COc1cccc(C(=O)C2=C(O)C(=O)N(CC(C)O)C2c2ccc(C(C)C)cc2)c1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ANXA2 P07355 8/20 0.68
S100A10 P60903 8/20 0.68
ALDH1A1 P00352 2/20 0.46
FPR1 P21462 1/20 0.46
CYP2C19 P33261 1/20 0.46
HIF1A Q16665 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.41
KDM4E B2RXH2 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TP53 P04637 1/20 0.40
MDM2 Q00987 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2236184 0.89 ANXA2 (0.55) ANXA2S100A10CYP2C19MEN1KMT2A
SCHEMBL2233843 0.87 ANXA2 (0.66) ANXA2S100A10ALDH1A1MEN1KMT2A
SCHEMBL2234809 0.87 ANXA2 (0.65) ANXA2S100A10ALDH1A1FPR1SMN1; SMN2
SCHEMBL2234993 0.81 ANXA2 (0.65) ANXA2S100A10ALDH1A1MEN1KMT2A
SCHEMBL2232974 0.81 ANXA2 (0.65) ANXA2S100A10ALDH1A1
SCHEMBL2298299 0.80 ANXA2 (0.67) ANXA2S100A10ALDH1A1MEN1KMT2A
SCHEMBL6115685 0.79 RXFP1 (0.51) ANXA2S100A10ALDH1A1HIF1AMEN1
SCHEMBL2233884 0.77 ANXA2 (0.67) ANXA2S100A10ALDH1A1MEN1KMT2A
SCHEMBL2237790 0.75 ANXA2 (0.68) ANXA2S100A10ALDH1A1FPR1SMN1; SMN2
SCHEMBL3472780 0.73 STS (0.59) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011092505-A1 S100 PROTEIN BINDING INTERACTION INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2011-08-04 WO claimed
WO-2011092505-A1 S100 PROTEIN BINDING INTERACTION INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2011-08-04 WO disclosed